IPO

Innova Captab Limited IPO

Mainboard

Pharmaceuticals

Listed On: Dec 29, 2023 at ₹ 452.1(NSE)

₹ 14784 /33 Shares

Check Allotment

21 Dec, 2023

Open Date

26 Dec, 2023

Close Date

27 Dec, 2023

Allotment Date

29 Dec, 2023

Listing Date
Price Summary

Last Closing

689.90 (54%)

52 Week High

1,260.00

52 Week Low

660.00

Last Update

19-Dec-2025 3:30 PM
Innova Captab Limited IPO Issue Details
  • Issue Price ₹426-448 per equity share
  • Face Value ₹10 Per Equity Share
  • Issue Price Total ₹570.00 Cr :
    #Fresh Issue: 7,142,857 shares (aggregating up to ₹320.00 Cr)
    #Offer for Sale: 5,580,357 shares of ₹10 (aggregating up to ₹250.00 Cr)
  • Listing at BSE, NSE
  • List Price 452.1(NSE)
  • Listing Date 2023-12-29
  • Lead Manager ICICI Securities Limited
    Jm Financial Limited
  • Registrar Kfin Technologies Limited
Innova Captab Limited IPO Details
  • Retail Portion 35% (Number of Retail Applications: 1,34,943 Approx),
    (Number of S-HNI Applications : 1,377 Approx),
    (Number of B-HNI Applications : 2,754 Approx)
Innova Captab Limited IPO Documents
DRHP
RHP
ANCHOR
Innova Captab Limited IPO Details


The IPO of Innova Captab Limited is priced at ₹426-448 per equity share, which has a face value of ₹10 Per Equity Share each, IPO bidding starts from Dec 21, 2023 and ends on Dec 26, 2023. The allotment for Innova Captab Limited IPO will be finalized on Dec 27, 2023. Innova Captab Limited IPO will be listed on BSE, NSE, with a tentative listing date fixed as Dec 29, 2023. The company shall list its equity shares on the BSE, NSE. Kfin Technologies Limited is the registrar of the issue.

The book-running lead manager for the IPO is/are ICICI Securities Limited, Jm Financial Limited.


The Innova Captab Limited IPO sets its price band at 426-448 for each share. A single application for Innova Captab Limited IPO must contain at least 33 shares.

Read More
Innova Captab Limited IPO Subscription Analysis And Details
Retail
17.12x
QIB
116.73x
NII
64.94x
bNII
71.59x
sNII
51.63x
Total
55.24x
As on QIB NII
bNII   sNII 		Retail Total
Shares Offered / Reserved 2,544,643 1,908,482
1,272,322    636,161 		4,453,125 8,906,250
Day 1 21-12-23 05:00 PM
0.44 x 0.96
1.04 x   0.93 x 		2.13 x 1.41 x
Day 2 22-12-23 05:00 PM
1.09 x 3.28
4.35 x   2.74 x 		5.02 x 3.54 x
Day 3 26-12-23 05:00 PM
116.73 x 64.94
71.59 x   51.63 x 		17.12 x 55.24 x
Total No of Applications
2,392,340
Innova Captab Limited Valuations
Earnings Per Share (EPS) ₹14.16/-
P/E Ratio 31.64
RoNW 24.58%
Net Asset Value (NAV) - As on 31.03.22 ₹N/A
Innova Captab Limited Company Financials
In Crs.
In Cr.
31-Mar-23 31-Mar-22 31-Mar-21
Assets 704.41 575.48 369.62
Revenue 935.58 803.41 412.03
Profit After Tax 67.95 63.95 34.50
About Innova Captab Limited Company

Innova Captab Limited is a pharmaceutical company operating in three business segments. Firstly, it provides contract development and manufacturing services to Indian pharmaceutical companies. Secondly, the company has a domestic business dealing in branded generics. And thirdly, the company has an international business that deals in branded generics.

The company's product portfolio includes tablets, capsules, dry syrups, dry powder injections, ointments and liquid medicines.

In the financial year 2023 and the three months ended June 30, 2023, the company produced and sold more than 600 different types of generics. These products were distributed under the company's own brands in the Indian market through a network of approximately 5,000 distributors and stockists and over 150,000 retail pharmacies. In addition, Innova Capitab exported its branded generic products to 20 and 16 countries in FY2023 and the three months ended June 30, 2023, respectively.

As of October 31, 2023, the company employed a team of 29 scientists and engineers in its research and development laboratory. The company's manufacturing facility is located in Buddi, Haryana.

The company's customer base includes Cipla Limited, Glenmark Pharmaceuticals Limited, Wockhardt Limited, Corona Remedies Private Limited, Emcure Pharmaceuticals Limited, Lupin Limited, Intas Pharmaceuticals Limited, Leeford Healthcare Limited, Medley Pharmaceuticals Limited, Cachet Pharmaceuticals Limited, Eris Healthcare Private Limited, Indoco Remedies Limited, J. B. Chemicals and Pharmaceuticals Limited, Oaknet Healthcare Private Limited, Zuventus Healthcare Limited, Ajanta Pharma Limited, Mankind Pharma Limited and Smart Laboratories Private Limited.

As of October 31, 2023, the company has 200 active product registrations and 20 registrations pending renewal with international authorities. In addition, 218 new registration applications are being processed with international authorities.

Read More
Innova Captab Limited - Promoter(s)

Manoj Kumar Lohariwala

Vinay Kumar Lohariwala

Pre Issue Share Holding : 66.85%

Post Issue Share Holding : 51.68%

Innova Captab Limited IPO - Issue Objectives
1

Repayment and / or prepayment in part or in full, of certain outstanding loans of the Company

2

Investment in the Subsidiary, UML, for repayment and / or prepayment in part or full of outstanding loans availed by UML

3

Funding the working capital requirements

4

General corporate purposes

Innova Captab Limited IPO - Anchor Investors

Innova Captab IPO Anchor investors pick Rs 171 crore worth shares.

Several institutional investors including Morgan Stanley, Copthall Mauritius Investment, ICICI Prudential Mutual Fund, Kotak Mahindra Trustee, Ashoka Whiteoak Emerging Markets Trust, SBI Life Insurance Company, Bandhan Mutual Fund, Canara Robeco Mutual Fund, Aditya Birla Sun Life Insurance Company, Invesco India, and Integrated Core Strategies invested in the company via anchor book.